Advanced search
Publication Cover
Future Neurology Volume 4, 2008 - Issue 1
Submit an article Journal homepage
59
Views
0
CrossRef citations to date
0
Altmetric
Review

LRP1 and Cerebral Amyloid Angiopathy

Takahisa Kanekiyoa Department of Pediatrics, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8208, St Louis, MO63110, USA Tel.: +1 314 286 2871 Fax: +1 314 286 [email protected]View further author information
&
Guojun Bub Departments of Pediatrics & Cell Biology & Physiology, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8208, St Louis, MO63110, USA Tel.: +1 314 286 2860 Fax: +1 314 286 [email protected]Correspondence[email protected]
View further author information
Pages 55-65 | Published online: 18 Dec 2008

Bibliography

  • Vinters HV : Cerebral amyloid angiopathy. A critical review.Stroke18, 311–324 (1987).
  • Iwamoto N , IshiharaT, ItoH, UchinoF: Morphological evaluation of amyloid-laden arteries in leptomeninges, cortices and subcortices in cerebral amyloid angiopathy with subcortical hemorrhage.Acta Neuropathol.86, 418–421 (1993).
  • Coria F , RubioI: Cerebral amyloid angiopathies.Neuropathol. Appl. Neurobiol.22, 216–227 (1996).
  • Rensink AA , de Waal RM, Kremer B, Verbeek MM: Pathogenesis of cerebral amyloid angiopathy. Brain Res. Rev.43, 207–223 (2003).
  • Revesz T , GhisoJ, LashleyTet al.: Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view.J. Neuropathol. Exp. Neurol.62, 885–898 (2003).
  • Maia LF , MackenzieIR, FeldmanHH: Clinical phenotypes of cerebral amyloid angiopathy.J. Neurol. Sci.257, 23–30 (2007).
  • Thal DR , GriffinWS, de Vos RA, Ghebremedhin E: Cerebral amyloid angiopathy and its relationship to Alzheimer‘s disease. Acta Neuropathol.115, 599–609 (2008).
  • Selkoe DJ : Alzheimer‘s disease: genes, proteins, and therapy.Physiol. Rev.81, 741–766 (2001).
  • Hardy J , SelkoeDJ: The amyloid hypothesis of Alzheimer‘s disease: progress and problems on the road to therapeutics.Science297, 353–356 (2002).
  • Hyman BT , StricklandD, RebeckGW: Role of the low-density lipoprotein receptor-related protein in β-amyloid metabolism and Alzheimer disease.Arch. Neurol.57, 646–650 (2000).
  • Bu G , CamJ, ZerbinattiC: LRP in amyloid-β production and metabolism.Ann. NY Acad. Sci.1086, 35–53 (2006).
  • May P , WoldtE, MatzRL, BoucherP: The LDL receptor-related protein (LRP) family: an old family of proteins with new physiological functions.Ann. Med.39, 219–228 (2007).
  • Herz J , BockHH: Lipoprotein receptors in the nervous system.Annu. Rev. Biochem.71, 405–434 (2002).
  • Herz J , StricklandDK: LRP: a multifunctional scavenger and signaling receptor.J. Clin. Invest.108, 779–784 (2001).
  • Jeon H , MengW, TakagiJ, EckMJ, SpringerTA, BlacklowSC: Implications for familial hypercholesterolemia from the structure of the LDL receptor YWTD–EGF domain pair.Nat. Struct. Biol.8, 499–504 (2001).
  • Lillis AP , MikhailenkoI, StricklandDK: Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability.J. Thromb. Haemost.3, 1884–1893 (2005).
  • Boucher P , GotthardtM, LiWP, AndersonRG, HerzJ: LRP: role in vascular wall integrity and protection from atherosclerosis.Science300, 329–332 (2003).
  • Herz J , HuiDY: Lipoprotein receptors in the vascular wall.Curr. Opin. Lipidol.15, 175–181 (2004).
  • Okada SS , GrobmyerSR, BarnathanES: Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion.Arterioscler. Thromb. Vasc. Biol.16, 1269–1276 (1996).
  • Li Y , LuW, BuG: Essential role of the low density lipoprotein receptor-related protein in vascular smooth muscle cell migration.FEBS Lett.555, 346–350 (2003).
  • Yepes M , SandkvistM, MooreEG, BuggeTH, StricklandDK, LawrenceDA: Tissue-type plasminogen activator induces opening of the blood–brain barrier via the LDL receptor-related protein.J. Clin. Invest.112, 1533–1540 (2003).
  • Bu G , GeuzeHJ, StrousGJ, SchwartzAL: 39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein.EMBO J.14, 2269–2280 (1995).
  • Bu G : The roles of receptor-associated protein (RAP) as a molecular chaperone for members of the LDL receptor family.Int. Rev. Cytol.209, 79–116 (2001).
  • Bu G , MarzoloMP: Role of rap in the biogenesis of lipoprotein receptors.Trends Cardiovasc. Med.10, 148–155 (2000).
  • Herz J , ClouthierDE, HammerRE: LDL receptor-related protein internalizes and degrades uPA–PAI-1 complexes and is essential for embryo implantation.Cell71, 411–421 (1992).
  • Shibata M , YamadaS, KumarSRet al.: Clearance of Alzheimer‘s amyloid-β1–40 peptide from brain by LDL receptor-related protein-1 at the blood–brain barrier.J. Clin. Invest.106, 1489–1499 (2000).
  • Deane R , WuZ, SagareAet al.: LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms.Neuron43, 333–344 (2004).
  • Ulery PG , BeersJ, MikhailenkoIet al.: Modulation of β-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer‘s disease.J. Biol. Chem.275, 7410–7415 (2000).
  • Pietrzik CU , BusseT, MerriamDE, WeggenS, KooEH: The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing.EMBO J.21, 5691–5700 (2002).
  • Kang DE , SaitohT, ChenXet al.: Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an Apolipoprotein E receptor, with late-onset Alzheimer‘s disease.Neurology49, 56–61 (1997).
  • Kang DE , PietrzikCU, BaumLet al.: Modulation of amyloid β-protein clearance and Alzheimer‘s disease susceptibility by the LDL receptor-related protein pathway.J. Clin. Invest.106, 1159–1166 (2000).
  • Pritchard A , HarrisJ, PritchardCWet al.: Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer‘s disease.Neurosci. Lett.382, 221–226 (2005).
  • Forero DA , ArboledaG, YunisJJ, PardoR, ArboledaH: Association study of polymorphisms in LRP1, tau and 5-HTT genes and Alzheimer‘s disease in a sample of Colombian patients.J. Neural Transm.113, 1253–1262 (2006).
  • Wattendorff AR , BotsGT, WentLN, EndtzLJ: Familial cerebral amyloid angiopathy presenting as recurrent cerebral haemorrhage.J. Neurol. Sci.55, 121–135 (1982).
  • Levy E , CarmanMD, Fernandez-MadridIJet al.: Mutation of the Alzheimer‘s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.Science248, 1124–1126 (1990).
  • Iglesias S , ChaponF, BaronJC: Familial occipital calcifications, hemorrhagic strokes, leukoencephalopathy, dementia, and external carotid dysplasia.Neurology55, 1661–1667 (2000).
  • Grabowski TJ , ChoHS, VonsattelJP, Rebeck GW, Greenberg SM: Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann. Neurol.49, 697–705 (2001).
  • McCarron MO , NicollJA: Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage.Lancet Neurol.3, 484–492 (2004).
  • Ellis RJ , OlichneyJM, ThalLJet al.: Cerebral amyloid angiopathy in the brains of patients with Alzheimer‘s disease: the CERAD experience, Part XV.Neurology46, 1592–1596 (1996).
  • Neuropathology Group of the Medical Research Council Cognitive Function and Aging Study: Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet357, 169–175 (2001).
  • Imaoka K , KobayashiS, FujiharaS, ShimodeK, NagasakiM: Leukoencephalopathy with cerebral amyloid angiopathy: a semiquantitativeand morphometric study.J. Neurol.246, 661–666 (1999).
  • Zarow C , ZaiasB, LynessSA, ChuiH: Cerebral amyloid angiopathy in Alzheimer disease is associated with Apolipoprotein E4 and cortical neuron loss.Alzheimer Dis. Assoc. Disord.13, 1–8 (1999).
  • Attems J : Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms.Acta Neuropathol.110, 345–359 (2005).
  • Vinters HV , WangZZ, SecorDL: Brain parenchymal and microvascular amyloid in Alzheimer‘s disease.Brain Pathol.6, 179–195 (1996).
  • Vonsattel JP , MyersRH, Hedley-WhyteET, RopperAH, BirdED, RichardsonEP Jr: Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann. Neurol.30, 637–649 (1991).
  • Yamaguchi H , YamazakiT, LemereCA, FroschMP, SelkoeDJ: b amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer‘s disease. An immunoelectron microscopic study.Am. J. Pathol.141, 249–259 (1992).
  • Miyakawa T , KimuraT, HirataSet al.: Role of blood vessels in producing pathological changes in the brain with Alzheimer‘s disease.Ann. NY Acad. Sci.903, 46–54 (2000).
  • Roher AE , LowensonJD, ClarkeSet al.: β-amyloid1–42 is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.Proc. Natl Acad. Sci. USA90, 10836–10840 (1993).
  • Burgermeister P , CalhounME, WinklerDT, JuckerM: Mechanisms of cerebrovascular amyloid deposition. Lessons from mouse models.Ann. NY Acad. Sci.903, 307–316 (2000).
  • Robbins EM , BetenskyRA, DomnitzSBet al.: Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease.J. Neurosci.26, 365–371 (2006).
  • Schroeter S , KhanK, BarbourRet al.: Immunotherapy reduces vascular amyloid-β in PDAPP mice.J. Neurosci.28, 6787–6793 (2008).
  • Calhoun ME , BurgermeisterP, PhinneyALet al.: Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid.Proc. Natl Acad. Sci. USA96, 14088–14093 (1999).
  • Weller RO , SubashM, PrestonSD, MazantiI, CarareRO: Perivascular drainage of amyloid-β peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer‘s disease.Brain Pathol.18, 253–266 (2008).
  • Carare RO , Bernardes-SilvaM, NewmanTAet al.: Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology.Neuropathol. Appl. Neurobiol.34, 131–144 (2008).
  • Zlokovic BV : Neurovascular mechanisms of Alzheimer‘s neurodegeneration.Trends Neurosci.28, 202–208 (2005).
  • Zlokovic BV : Clearing amyloid through the blood–brain barrier.J. Neurochem.89, 807–811 (2004).
  • Paris D , TownsendK, QuadrosAet al.: Inhibition of angiogenesis by Aβ peptides.Angiogenesis7, 75–85 (2004).
  • Wyss-Coray T , LoikeJD, BrionneTCet al.: Adult mouse astrocytes degrade amyloid-β in vitro and in situ.Nat. Med.9, 453–457 (2003).
  • Schenk D , BarbourR, DunnWet al.: Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse.Nature400, 173–177 (1999).
  • Iwata N , TsubukiS, TakakiYet al.: Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition.Nat. Med.6, 143–150 (2000).
  • Iwata N , TsubukiS, TakakiYet al.: Metabolic regulation of brain Aβ by neprilysin.Science292, 1550–1552 (2001).
  • Vekrellis K , YeZ, QiuWQet al.: Neurons regulate extracellular levels of amyloid β-protein via proteolysis by insulin-degrading enzyme.J. Neurosci.20, 1657–1665 (2000).
  • Blomqvist ME , ChalmersK, AndreasenNet al.: Sequence variants of IDE are associated with the extent of β-amyloid deposition in the Alzheimer‘s disease brain.Neurobiol. Aging26, 795–802 (2005).
  • Farris W , SchutzSG, CirritoJRet al.: Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy.Am. J. Pathol.171, 241–251 (2007).
  • Miners JS , Van Helmond Z, Chalmers K, Wilcock G, Love S, Kehoe PG: Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. J. Neuropathol. Exp. Neurol.65, 1012–1021 (2006).
  • Miller BC , EckmanEA, SambamurtiKet al.: Amyloid-β peptide levels in brain are inversely correlated with insulysin activity levels in vivo.Proc. Natl Acad. Sci. USA100, 6221–6226 (2003).
  • Urmoneit B , PrikulisI, WihlGet al.: Cerebrovascular smooth muscle cells internalize Alzheimer amyloid β protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy.Lab. Invest.77, 157–166 (1997).
  • Wilhelmus MM , Otte-HollerI, van Triel JJet al.: Lipoprotein receptor-related protein-1 mediates amyloid-β-mediated cell death of cerebrovascular cells. Am. J. Pathol.171, 1989–1999 (2007).
  • Abbott NJ , RonnbackL, HanssonE: Astrocyte–endothelial interactions at the blood–brain barrier.Nat. Rev. Neurosci.7, 41–53 (2006).
  • Zlokovic BV , MartelCL, MatsubaraEet al.: Glycoprotein 330/megalin: probable role in receptor-mediated transport of Apolipoprotein J alone and in a complex with Alzheimer disease amyloid β at the blood–brain and blood–cerebrospinal fluid barriers.Proc. Natl Acad. Sci. USA93, 4229–4234 (1996).
  • Lam FC , LiuR, LuPet al.: β-amyloid efflux mediated by p-glycoprotein.J. Neurochem.76, 1121–1128 (2001).
  • Deane R , Du Yan S, Submamaryan RKet al.: RAGE mediates amyloid-β peptide transport across the blood–brain barrier and accumulation in brain. Nat. Med.9, 907–913 (2003).
  • Van Uden E , MalloryM, VeinbergsI, AlfordM, RockensteinE, MasliahE: Increased extracellular amyloid deposition and neurodegeneration in human amyloid precursor protein transgenic mice deficient in receptor-associated protein.J. Neurosci.22, 9298–9304 (2002).
  • Giri R , ShenY, StinsMet al.: β-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1.Am. J. Physiol. Cell. Physiol.279, C1772–C1781 (2000).
  • Marzolo MP , von Bernhardi R, Bu G, Inestrosa NC: Expression of α2-macroglobulin receptor/low density lipoprotein receptor-related protein (LRP) in rat microglial cells. J. Neurosci. Res.60, 401–411 (2000).
  • Bu G , MaksymovitchEA, NerbonneJM, SchwartzAL: Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons.J. Biol. Chem.269, 18521–18528 (1994).
  • Arelin K , KinoshitaA, WhelanCMet al.: LRP and senile plaques in Alzheimer‘s disease: colocalization with Apolipoprotein E and with activated astrocytes.Brain Res. Mol. Brain Res.104, 38–46 (2002).
  • Qiu Z , StricklandDK, HymanBT, RebeckGW: α2-macroglobulin enhances the clearance of endogenous soluble β-amyloid peptide via low-densitylipoprotein receptor-related protein incortical neurons.J. Neurochem.73, 1393–1398 (1999).
  • Gylys KH , FeinJA, TanAM, ColeGM: Apolipoprotein E enhances uptake of soluble but not aggregated amyloid-β protein into synaptic terminals.J. Neurochem.84, 1442–1451 (2003).
  • Wang DS , DicksonDW, MalterJS: β-amyloid degradation and Alzheimer‘s disease.J. Biomed. Biotechnol.2006, 58406 (2006).
  • Narita M , HoltzmanDM, SchwartzAL, BuG: α2-macroglobulin complexes with and mediates the endocytosis of β-amyloid peptide via cell surfacelow-density lipoprotein receptor-related protein.J. Neurochem.69, 1904–1911 (1997).
  • Jordan J , GalindoMF, MillerRJ, ReardonCA, GetzGS, LaDuMJ: Isoform-specific effect of Apolipoprotein E on cell survival and β-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures.J. Neurosci.18, 195–204 (1998).
  • Rebeck GW , HarrSD, StricklandDK, HymanBT: Multiple, diverse senile plaque-associated proteins are ligands of an Apolipoprotein E receptor, the α2-macroglobulin receptor/low-density-lipoprotein receptor-related protein.Ann. Neurol.37, 211–217 (1995).
  • Ito S , OhtsukiS, TerasakiT: Functional characterization of the brain-to-blood efflux clearance of human amyloid-β peptide (1–40) across the rat blood–brain barrier.Neurosci. Res.56, 246–252 (2006).
  • Bell RD , SagareAP, FriedmanAEet al.: Transport pathways for clearance of human Alzheimer‘s amyloid β-peptide and Apolipoproteins E and J in the mouse central nervous system.J. Cereb. Blood Flow Metab.27, 909–918 (2007).
  • Hyman BT : Apolipoprotein E genotype: utility in clinical practice in Alzheimer‘s disease.J. Am. Geriatr. Soc.44, 1469–1471 (1996).
  • Blacker D , WilcoxMA, LairdNMet al.: α-2 macroglobulin is genetically associated with Alzheimer disease.Nat. Genet.19, 357–360 (1998).
  • Liao A , NitschRM, GreenbergSMet al.: Genetic association of an α2-macroglobulin (Val1000lle) polymorphism and Alzheimer‘s disease.Hum. Mol. Genet.7, 1953–1956 (1998).
  • Greenberg SM , BriggsME, HymanBTet al.: Apolipoprotein E e4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy.Stroke27, 1333–1337 (1996).
  • McCarron MO , NicollJA: Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage.Ann. NY Acad. Sci.903, 176–179 (2000).
  • Walsh DM , KlyubinI, FadeevaJVet al.: Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo.Nature416, 535–539 (2002).
  • Cleary JP , WalshDM, HofmeisterJJet al.: Natural oligomers of the amyloid-β protein specifically disrupt cognitive function.Nat. Neurosci.8, 79–84 (2005).
  • Christoforidis M , SchoberR, KrohnK: Genetic-morphologic association study: association between the low density lipoprotein-receptor related protein (LRP) and cerebral amyloid angiopathy.Neuropathol. Appl. Neurobiol.31, 11–19 (2005).
  • Shi J , TianJ, PritchardAet al.: A 3´-UTR polymorphism in the oxidized LDL receptor 1 gene increases Aβ40 load as cerebral amyloid angiopathy in Alzheimer‘s disease.Acta Neuropathol.111, 15–20 (2006).
  • Sagare A , DeaneR, BellRDet al.: Clearance of amyloid-β by circulating lipoprotein receptors.Nat. Med.13, 1029–1031 (2007).
  • Bu G , SunY, SchwartzAL, HoltzmanDM: Nerve growth factor induces rapid increases in functional cell surface low density lipoprotein receptor-related protein.J. Biol. Chem.273, 13359–13365 (1998).
  • Gauthier A , VassiliouG, BenoistF, McPhersonR: Adipocyte low density lipoprotein receptor-related protein gene expression and function is regulated by peroxisome proliferator-activated receptor γ.J. Biol. Chem.278, 11945–11953 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.